treatment of diabetes in patients with liver disease. Expert Opin Drug Metab
Toxicol. 2014;10:839-5
65. Lamont, Benjamin J, Daniel J Drucker. Differential Antidiabetic Efficacy  of
Incretin Agonists Versus DPP -4 Inhibition in High Fat -Fed Mice. Diabetes.
2008;57(1):190-99
66. M
icromedex Solutions. Sitagliptin phosphate. http://www.micromedex
solutions.com.ezproxy.uthsc.edu. Accessed July 7, 2014.
67. Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ. SGLT inhibitors
and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes.
2013;6:453-67
68. T
jandrawinata RR, Nofiarny D, Suastika K. DLBS3233 extract, a novel
insulin sensitizer with negligible risk of hypoglycemia: A phase -I study. Int
J Diab and Metab. 2012,21(1):13-20
69. G
arber AJ , Abrahamson MJ , BarzilayJI, et al. AACE Comprehensive